Knightsbridge Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$898K Buy
7,463
+47
+0.6% +$5.43K 0.12% 90
2025
Q4
$781K Buy
7,416
+2,956
+66% +$277K 0.13% 82
2025
Q3
$374K Buy
+4,460
New +$367K 0.06% 113
2024
Q2
Sell
-2,010
Closed -$219K 129
2024
Q1
$219K Hold
2,010
0.06% 110
2023
Q4
$219K Buy
+2,010
New +$209K 0.06% 110

Other funds holding MRK

Knightsbridge Asset Management's MRK Position: Q1 2026 in Review

Knightsbridge Asset Management increased its Merck (MRK) stake by 0.63% in Q1 2026, buying an estimated $5.43K and bringing the position to 7,463 shares worth $898K. The position accounts for 0.12% of the portfolio, ranked #90.

Knightsbridge Asset Management first reported a position in MRK in Q4 2023 and has held it in 5 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Knightsbridge Asset Management held 7,463 shares of Merck worth $898K as of Q1 2026.
  • Knightsbridge Asset Management bought 47 Merck shares in Q1 2026, an estimated $5.43K.
  • Merck made up 0.12% of Knightsbridge Asset Management's portfolio in Q1 2026, its #90 holding.
  • Knightsbridge Asset Management first reported a position in Merck in Q4 2023 and has held it in 5 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.